AB vs CNS
Head-to-Head Stock Analysis & Investment Rating
Last Updated: Aug 04, 2026
AB
CNS
Investment Advisor Scores
CNS
AI Analyst Insights
Detailed Metrics Comparison
| Metric | AB | CNS | Winner |
|---|---|---|---|
|
Valuation
Lower P/E and PEG ratios suggest a stock may be undervalued relative to earnings and growth. Value investors prefer lower multiples. |
|||
| Forward P/E | 10.5042 | 23.0947 | AB |
| PEG Ratio | 0.6343 | 2.0634 | AB |
|
Growth
Higher revenue and earnings growth rates indicate a company is expanding faster. Strong growth often justifies premium valuations. |
|||
| Revenue Growth | -40.3% | 12.2% | CNS |
| Earnings Growth | 20.9% | 31.9% | CNS |
|
Quality & Profitability
Higher Tradestie Score and profit margins reveal how efficiently a company operates. Strong profitability indicates competitive advantages. |
|||
| Tradestie Score | 41.1/100 | 55.5/100 | CNS |
| Profit Margin | 390.6% | 28.8% | AB |
|
Risk Profile
Lower Beta and Implied Volatility values indicate reduced market risk. Conservative investors favor stocks with less price volatility. |
|||
| Beta | 1.00 | 1.00 | Tie |
|
Sentiment
AI Recommendation reflects overall analyst and proprietary sentiment. Stronger recommendations signal higher conviction. |
|||
| AI Recommendation | HOLD | HOLD | Tie |
Relative Price Performance (Last 90 Days)
Current Technical Phase
AB
DistributionPrice near a flattening SMA50 (slope -1.7%) with fading momentum, RSI 49
CNS
MarkupPrice above SMA50, rising 50-day trend (5.5% over 20 days), RSI 66
Fundamentals Snapshot
| Metric | AB | CNS |
|---|---|---|
| Market Cap | — | — |
| Forward P/E | 9.5 | 21.8 |
| Trailing P/E | 11.0 | 25.3 |
| Revenue (TTM) | — | — |
| Revenue Growth | -0.4% | 0.1% |
| Gross Margin | 1.0% | 0.5% |
| Operating Margin | 1.0% | 0.3% |
| EPS | 3.35 | 3.25 |
| Dividend Yield | 0.09% | 0.03% |